Navigation Links
Ore Pharmaceutical Holdings Announces Name Change and Reverse/Forward Stock Split to be Effective June 10, 2011
Date:6/6/2011

CAMBRIDGE, Mass., June 6, 2011 /PRNewswire/ -- Ore Pharmaceutical Holdings Inc. ("Ore") announced today that, pursuant to the authorization granted by the stockholders of Ore, the Board of Directors of Ore (the "Board") approved and authorized a 1-for-10,000 reverse stock split (the "Reverse Stock Split") of Ore's common stock, $0.01 par value (the "Common Stock"), such that stockholders owning fewer than the amount necessary to receive at least one share of post-split Common Stock (the "Cashed Out Stockholders"), and remaining stockholders holding fractional shares after the Reverse Stock Split, will have such pre-split shares cancelled and converted into the right to receive certain cash consideration, immediately followed by a 10,000-for-1 forward stock split of the Common Stock (the "Forward Stock Split" and together with the Reverse Stock Split, the "Reverse/Forward Stock Split"). The Reverse/Forward Split is expected to be effective June 10, 2011. It is anticipated that the Common Stock will begin trading on the Pink Sheets on a post-split basis at the opening of trading on June 13, 2011 under its current symbol "ORXE.PK".

As previously announced, at the 2011 Annual Meeting of Stockholders of Ore, stockholders approved a name change of Ore from "Ore Pharmaceutical Holdings Inc." to "Ore Holdings, Inc." Ore intends to effect the name change concurrently with the Reverse/Forward Stock Split.

No fractional shares of Common Stock will be issued as a result of the implementation of the Reverse/Forward Split.  Instead, BNY Mellon, our transfer agent, will aggregate all fractional shares of Cashed Out Stockholders and any fractional shares of remaining stockholders after the Reverse/Forward Split and sell them as soon as practicable after the effective time at the then prevailing prices on the open market, on behalf of those stockholders who would otherwise be entitled to receive a fractional share.  We expect that the transfer agent will c
'/>"/>

SOURCE Ore Holdings Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aeolus Pharmaceuticals, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
2. Onyx Pharmaceuticals to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
3. Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia
4. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
6. Vanda Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
7. Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat
8. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
9. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Jefferies 2011 Global Healthcare Conference on June 9, 2011
10. Isis Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
11. Jazz Pharmaceuticals Announces Presentation at the Jefferies 2011 Global Healthcare Conference in New York on June 8
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...  Novastem, a leader in regenerative medicine, announces ... study for ischemic stroke at Clinica Santa Clarita. ... account for 87 percent of all stroke cases. ... study, entitled "Internal Research Protocol in Combination Therapy ... and Intrathecal Administration of Neural Stem Cells in ...
(Date:12/24/2014)... 2014  Commonwealth Cornerstone Group (CCG) today announced the completion ... Tuesday to help fund the expansion and consolidation of healthcare ... Sharon . PHN is the largest ... . It is the largest employer in Sharon,s ... on staff. Currently, PHN Sharon offers scattered services ...
(Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals announced ... KX2-361 at Roswell Park Cancer Institute. KX2-361 ... drug that has shown potent inhibitory activity against a ... that are resistant to Temozolomide (T98G), the most widely ... a well-established brain tumor mouse model, KX2-361 consistently clears ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3
... Reportlinker.com announces that a new ... its catalogue: European ... Suppliers http://www.reportlinker.com/p0651441/European-Chemical-Market-Strategic-Assessments-of-Leading-Suppliers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Over-The-Counter_Drug ... chemical industry executives with strategically significant ...
... Oct. 5, 2011 Reportlinker.com announces ... is available in its catalogue: ... Strategic Assessments of Leading Suppliers ... This report provides industry executives ...
Cached Medicine Technology:European Chemical Market: Strategic Assessments of Leading Suppliers 2European Chemical Market: Strategic Assessments of Leading Suppliers 3European Chemical Market: Strategic Assessments of Leading Suppliers 4European Chemical Market: Strategic Assessments of Leading Suppliers 5European Chemical Market: Strategic Assessments of Leading Suppliers 6European Chemical Market: Strategic Assessments of Leading Suppliers 7European Chemical Market: Strategic Assessments of Leading Suppliers 8Global Oncology Drug Market: Strategic Assessments of Leading Suppliers 2Global Oncology Drug Market: Strategic Assessments of Leading Suppliers 3Global Oncology Drug Market: Strategic Assessments of Leading Suppliers 4Global Oncology Drug Market: Strategic Assessments of Leading Suppliers 5Global Oncology Drug Market: Strategic Assessments of Leading Suppliers 6Global Oncology Drug Market: Strategic Assessments of Leading Suppliers 7
(Date:12/24/2014)... Today, Yunx.co.uk, a hot style dress supplier ... special occasion outfits, unveils 65 new bridesmaid dresses ... discounted prices, up to 80% off. , Yunx.co.uk’s dresses ... fashionable designs, gorgeous looks and delicate craftsmanship. These new ... devoted to designing and offering high-quality women’s dresses with ...
(Date:12/24/2014)... December 24, 2014 Mike Billings ... down with Derek Fenwick, PT, MBA, GCS, Director ... will stem from the passing of the Improving ... Act). In this taping of the Infinicast, the two ... of the Social Security Act to standardize post-acute assessment ...
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. 23, 2014 (HealthDay News) ... one year will be allowed to donate blood in the United ... ban on donations from men who have sex with men. ... release a new draft guidance in early 2015 that would ultimately ... FDA is changing its policy based on data from other countries ...
(Date:12/24/2014)... C infection does not contribute to mental decline in people ... have made it possible for people with HIV to survive ... swings and other types of mental impairment as they age, ... with other viruses -- a common problem in people with ... suspects has been the hepatitis C virus, which infects about ...
(Date:12/24/2014)... (HealthDay News) -- Adults who experienced childhood abuse ... headaches, suggests a study published online Dec. 24 ... maltreatment can have long-lasting effects, like associated medical ... author Dawn Buse, director of behavioral medicine at ... in a journal news release. "When managing ...
Breaking Medicine News(10 mins):Health News:Yunx.co.uk Unveils 65 New Bridesmaid Dresses for the UK market 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 3Health News:Hepatitis C Infection Isn't Related to HIV Brain Woes: Study 2Health News:Abuse in Childhood Tied to Migraines in Adulthood 2
... HEIGHTS, N.J., Oct. 27 Authentidate,Holding Corp. ... of secure workflow,management software and web-based services, ... healthcare agency, has implemented Authentidate,s,Inscrybe Healthcare service ... its extensive customer base in both Ohio ...
... virtually no gastrointestinal, side effects for people who need ... ... CHICAGO, Oct. 27 Announced today at the American,Dietetic ... offers both heme (protein-based iron) and non-heme,iron (plant-based iron) ...
... Frost & Sullivan is,pleased to present the ... Innovation Award to Lifeblood Medical. This is,in recognition ... a,myriad of advantages and has led to the ... solution. In addition to human,organ preservation, Lifeblood Medical,s ...
... to be Used in Early Lines of,Therapy, ... Resources, WALTHAM, Mass., Oct. 27 ... and advisory firms focusing on pharmaceutical and,healthcare ... the leading biologic for Crohn,s disease, but,Abbott/Eisai,s ...
... Across States, WASHINGTON, Oct. 27 Sixty-three percent ... Survey,indicated they have implemented Leapfrog,s Never Events Policy which,describes ... error --,that should never happen to a patient -- ... 2007, the policy,s first year., Leapfrog,s hospital survey ...
... November 1, 2008 at this year,s liver ... 4, SAN FRANCISCO, Oct. 27 Researchers analyzed ... and 22,863 adults,who received transplantation to determine the best ... posttransplant,mortality caused by differences in donor type was vastly ...
Cached Medicine News:Health News:WILLCARE Chooses Authentidate's Inscrybe(TM) Healthcare Service to Streamline Operations and Enhance Business Growth 2Health News:WILLCARE Chooses Authentidate's Inscrybe(TM) Healthcare Service to Streamline Operations and Enhance Business Growth 3Health News:WILLCARE Chooses Authentidate's Inscrybe(TM) Healthcare Service to Streamline Operations and Enhance Business Growth 4Health News:First-Ever Over-the-Counter Dual Action Iron Supplement Launched at the American Dietetic Association Conference in Chicago; Bifera to be Available in Select Stores in Early 2009 2Health News:Frost & Sullivan Recognizes Lifeblood Medical for Its Innovation in Organ Preservation and Development of the Lifor(R) Solution 2Health News:Frost & Sullivan Recognizes Lifeblood Medical for Its Innovation in Organ Preservation and Development of the Lifor(R) Solution 3Health News:Frost & Sullivan Recognizes Lifeblood Medical for Its Innovation in Organ Preservation and Development of the Lifor(R) Solution 4Health News:Humira to Replace Remicade as First Choice Among Biologics for the Treatment of Crohn's Disease 2Health News:Humira to Replace Remicade as First Choice Among Biologics for the Treatment of Crohn's Disease 3Health News:More Hospitals Adopting Leapfrog Group's 'Never Events' Policy Which Inculdes Apologies, Reporting, and Waiving Costs 2Health News:Early Liver Transplantation Regardless of Donor Type Increases Long-term Survival 2
Adjustable Velcro© closures at crown and behind the neck distinguish this immediate post-op face and chin garment for maximum support and compression....
Facial Wrap...
Very compressive support for submental liposuction...
Ideal for autoplasty and liposuction of chin and cheeks...
Medicine Products: